Sale by Christopher Ryan Sullivan (Chief Financial Officer)
16,915 shares · @ $13.16 · $222,589
Avalo Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.75
+59% in 3d after detection
Post-detection moves
1h
—
1d
+0.5%
3d
+59%
7d
+45%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS